诺氟沙星
共聚物
角鲨酸
乙二醇
聚合物
生物相容性
药物输送
化学
乳状液
聚酯纤维
材料科学
高分子化学
化学工程
核化学
有机化学
抗生素
生物化学
工程类
环丙沙星
作者
Alexandru‐Mihail Serban,Isabella Nacu,Irina Roșca,Alina Ghilan,Alina Gabriela Rusu,Loredana E. Niţă,Raluca Nicoleta Darie-Niță,Aurica P. Chiriac
出处
期刊:Pharmaceutics
[Multidisciplinary Digital Publishing Institute]
日期:2024-04-17
卷期号:16 (4): 550-550
被引量:4
标识
DOI:10.3390/pharmaceutics16040550
摘要
In recent years, increasing interest has been accorded to polyester-based polymer microstructures, driven by their promising potential as advanced drug delivery systems. This study presents the preparation and characterization of new polymeric microparticles based on poly(ethylene brassylate-co-squaric acid) loaded with norfloxacin, a broad-spectrum antibiotic. Polymacrolactone was synthesised in mild conditions through the emulsion polymerization of bio-based and renewable monomers, ethylene brassylate, and squaric acid. The microparticles were obtained using the precipitation technique and subsequently subjected to comprehensive characterization. The impact of the copolymer/drug ratio on various properties of the new system was systematically evaluated, confirming the structure of the copolymer and the encapsulation of norfloxacin. The microspheres are approximately spherical and predominantly homogeneously distributed. The average hydrodynamic diameter of the microparticles falls between 400 and 2000 nm, a decrease that is observed with the increase in norfloxacin content. All samples showed good encapsulation efficiency and drug loading capacity, with the highest values obtained for microparticles synthesised using an equal ratio of copolymer and drug. In vitro drug release results disclose that norfloxacin molecules are released in a sustained biphasic manner for up to 24 h. Antimicrobial activity was also studied, with samples showing very good activity against E. coli and moderate activity against S. aureus and E. faecalis. In addition, HDFA human fibroblast cell cultures demonstrated the cytocompatibility of the microparticles.
科研通智能强力驱动
Strongly Powered by AbleSci AI